Activity value 76china Buyer&Supplier,Last transaction date:
2026-03-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sinobright pharm ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 137 transactions, with a transaction quantity of 168755.07 and a transaction weight of 144086.91.
YearTransactionsQuantityWeight
2025678815008.392777110.71
2026137168755.07144086.91
Bill of lading data
<
1/15
>
Trade date
2026/03/31
B/L No.
108099491730
Suppliers
sinobright pharm ltd.
Buyers
công ty cp xuất nhập khẩu y tế domesco
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
9100
Hs code
29242910
Product tags
phenacetin
Product description
Nguyên liệu sản xuất thực phẩm chức năng ASPAMIC:ASPARTAM EP Current/USP Current;Lot:2603016DDP, SX: 02/26,HD:02/29,NSX: Vitasweet Co., Ltd - China.(NL dùng trong sx nội bộ, không tiêu thụ nội địa).
Expand
Trade date
2026/03/31
B/L No.
108099491730
Suppliers
sinobright pharm ltd.
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu sản xuất thuốc tân dược,loại kháng sinh:Amoxicillin Trihydrate(compacted) BP2025 ,Lô:2602140287,288,289,290,291,292,293,296,297,298,299. NSX:02/2026,HD:01/2030. NSX:The United Laborat.
Expand
Trade date
2026/03/26
B/L No.
108088612440
Suppliers
sinobright pharm ltd.
Buyers
công ty cổ phần dược phẩm opc
Product description
Flunarizine - EP hiện hành (dưới dạng Flunarizine dihydrochloride _ nguyên liệu sản xuất thuốc theo GPLH 893110379825) BATCH NO: FL251004F; SX: 09/10/2025 HD: 09/2027
Expand
sinobright pharm ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as neomycin sulphate,ceftriaxone sodium,entercavir.
According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 4547 international trades,
with its main trading regions covering vietnam,bangladesh,uzbekistan etc.
The core products include HS29419000,HS29411090,HS7010100000 etc,
often transported via shanghai,port shanghai cn, port hangzhou cn etc,
and its main trading partners are công ty cp xuất nhập khẩu y tế domesco,domesco medical imports export joint stock corp.,công ty tnhh phil inter pharma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sinobright pharm ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.